kras mutation and glutathion JCI KRAS-targeted therapies in cancer: novel
KRAS targeted therapies in cancer: novel approaches and overcoming resistance BMJ Oncology Kinetic and Redox Characterization of KRAS G12C Inhibition bioRxiv Uncovering new therapeutic targets for a common KRAS mutation behind cancer Targeting KRAS Mutant Cancers with a Covalent G12C Specific Inhibitor: Cell
Pay in 4 interest-free payments of $7.10 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15



